结直肠癌分子机制与治疗策略的进展：精准医学的新时代。
Advances in Molecular Mechanisms and Therapeutic Strategies in Colorectal Cancer: A New Era of Precision Medicine.
作者信息
Delle Cave Donatella
机构信息
Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso', National Research Council CNR, 80131 Naples, Italy.
出版信息
Int J Mol Sci. 2025 Jan 2;26(1):346. doi: 10.3390/ijms26010346.
Abstract
Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality worldwide [...].
摘要
结直肠癌（CRC）是全球范围内癌症相关发病和死亡的主要原因之一[...]。
相似文献
1
Advances in Molecular Mechanisms and Therapeutic Strategies in Colorectal Cancer: A New Era of Precision Medicine.结直肠癌分子机制与治疗策略的进展：精准医学的新时代。
Int J Mol Sci. 2025 Jan 2;26(1):346. doi: 10.3390/ijms26010346.
2
Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine.结直肠癌：精准医学的遗传基础与分子治疗。
Genes (Basel). 2024 Apr 25;15(5):538. doi: 10.3390/genes15050538.
3
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.涉及结直肠癌的信号通路：发病机制和靶向治疗。
Signal Transduct Target Ther. 2024 Oct 7;9(1):266. doi: 10.1038/s41392-024-01953-7.
4
State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation.结直肠癌的最新治疗进展：治疗进展与创新。
Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e438466. doi: 10.1200/EDBK_438466.
5
Precision medicine for metastatic colorectal cancer: an evolving era.精准医学治疗转移性结直肠癌：崭新时代。
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):919-931. doi: 10.1080/17474124.2019.1663174. Epub 2019 Sep 3.
6
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients.为何精准医学应应用于转移性结直肠癌患者的全程照护。
Future Oncol. 2020 Jan;16(2):4337-4339. doi: 10.2217/fon-2019-0624. Epub 2019 Dec 3.
7
Colorectal cancer: from prevention to personalized medicine.结直肠癌：从预防到个性化医疗
World J Gastroenterol. 2014 Jun 14;20(22):6786-808. doi: 10.3748/wjg.v20.i22.6786.
8
Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.精准化学预防结直肠癌的分子靶点：从临床前到临床试验的最新进展。
Int J Mol Sci. 2020 Dec 17;21(24):9609. doi: 10.3390/ijms21249609.
9
Systemic treatment for metastatic colorectal cancer in the era of precision medicine.精准医学时代转移性结直肠癌的全身治疗
J Surg Oncol. 2019 Apr;119(5):564-582. doi: 10.1002/jso.25421. Epub 2019 Feb 25.
10
Role of targeted agents in metastatic colorectal cancer.靶向药物在转移性结直肠癌中的作用。
Target Oncol. 2013 Jun;8(2):83-96. doi: 10.1007/s11523-013-0281-x. Epub 2013 May 5.
引用本文的文献
1
Single-cell technology reveals the crosstalk between tumor cells and immune cells: driving immune signal transduction and inflammation-mediated cardiac dysfunction in the tumor microenvironment of colorectal cancer.单细胞技术揭示肿瘤细胞与免疫细胞间的串扰：驱动免疫信号转导及炎症介导的结直肠癌肿瘤微环境中的心脏功能障碍
Front Immunol. 2025 Aug 6;16:1637144. doi: 10.3389/fimmu.2025.1637144. eCollection 2025.
2
Molecular Mechanisms and Clinical Implications of Complex Prehabilitation in Colorectal Cancer Surgery: A Comprehensive Review.结直肠癌手术中复杂术前康复的分子机制及临床意义：综述
Int J Mol Sci. 2025 Jul 26;26(15):7242. doi: 10.3390/ijms26157242.
本文引用的文献
1
Hybrid Biosilica Nanoparticles for in-vivo Targeted Inhibition of Colorectal Cancer Growth and Label-Free Imaging.用于体内靶向抑制结直肠癌生长和无标记成像的杂化生物硅纳米粒子。
Int J Nanomedicine. 2024 Nov 19;19:12079-12098. doi: 10.2147/IJN.S480168. eCollection 2024.
2
Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies.结直肠癌的分子复杂性：途径、生物标志物和治疗策略。
Cancer Manag Res. 2024 Oct 10;16:1389-1403. doi: 10.2147/CMAR.S481656. eCollection 2024.
3
Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges.基于无机纳米粒子的结直肠癌治疗方法：最新进展与挑战。
J Nanobiotechnology. 2024 Jul 19;22(1):427. doi: 10.1186/s12951-024-02701-3.
4
Genetic Insights into Colorectal Cancer: Evaluating PI3K/AKT Signaling Pathway Genes Expression.结直肠癌的遗传学研究：评估 PI3K/AKT 信号通路基因表达。
Int J Mol Sci. 2024 May 27;25(11):5806. doi: 10.3390/ijms25115806.
5
Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320.FOLFOXIRI 药物联合溶瘤柯萨奇 B3 病毒 PD-H 协同诱导耐药结直肠癌细胞系 Colo320 发生溶瘤作用。
Int J Mol Sci. 2024 May 22;25(11):5618. doi: 10.3390/ijms25115618.
6
TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis.TGFβ 反应性基质激活发生在锯齿状结直肠肿瘤发生的早期。
Int J Mol Sci. 2024 Apr 24;25(9):4626. doi: 10.3390/ijms25094626.
7
Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance.了解 DNA 甲基化在结直肠癌中的作用：机制、检测及临床意义。
Biochim Biophys Acta Rev Cancer. 2024 May;1879(3):189096. doi: 10.1016/j.bbcan.2024.189096. Epub 2024 Mar 17.
8
Novel Therapeutic Approaches for Colorectal Cancer Treatment.结直肠癌治疗的新治疗方法。
Int J Mol Sci. 2024 Feb 13;25(4):2228. doi: 10.3390/ijms25042228.
9
Targeting the TGF-β Signaling Axis in Metastatic Colorectal Cancer: Where Do We Stand?靶向转移性结直肠癌中的 TGF-β 信号轴：我们处于什么位置？
Int J Mol Sci. 2023 Dec 4;24(23):17101. doi: 10.3390/ijms242317101.
10
Anti-epidermal growth factor receptor treatment for patients with Neo wild-type metastatic colorectal cancer: a case report of two cases.抗表皮生长因子受体治疗新野生型转移性结直肠癌患者：两例病例报告
Ther Adv Med Oncol. 2023 Nov 28;15:17588359231216090. doi: 10.1177/17588359231216090. eCollection 2023.
Zotero 插件